TABLE 1:

National clinical trials (NCTs) utilizing CUR

NCT number	Title	Status	Intervention	Characteristics
NCT03072992	Curcumin in Combination with Chemotherapy in Advanced Breast Cancer	Completed	Curcumin (CUC-01) vs. Placebo, in combination with Paclitaxel	Interventional Phase 2
NCT01160302	An Exploratory Biomarker Trial of the Food Substances Curcumin C3 Complex® in Subjects with Newly Diagnosed Head and Neck Squamous Cell Carcinoma	Completed	Microgranular Curcumin C3 Complex	Interventional Early Phase 1
NCT02017353	Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma	Completed	Dietary Supplement: Curcuphyt	Interventional Phase 2
N/A	The New Combination Docetaxel, Prednisone, and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study	Completed	Docetaxel, Prednisone or Prenisolone, Curcumin	Interventional Phase 2
NCT01712542	Measurement of Intratumoral Concentration of the Nontoxic Natural Compound Curcumin in Glioblastoma Patients	Completed	Curcumin	Observational
NCT01740323	Meriva for Treatment-Induced Inflammation and Fatigue in Women with Breast Cancer	Completed	Meriva (Curcumin)	Interventional Phase 2
NCT02556632	Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis	Completed	HPR Plus or Curcumin	Interventional Phase 2